• Kevin McVeigh from UBS set a price target of $24.55 for NYSE:CWAN, closely aligning with the proposed sale price by Permira and Warburg Pincus.
• Kahn Swick & Foti, LLC is investigating the fairness of the proposed sale of CWAN, questioning the valuation and sale process.
• CWAN's current stock price is $24.18, with a year's trading range between $32 and $15.73, indicating notable market volatility.

Clearwater Analytics Holdings, Inc. (NYSE:CWAN) is a company that provides software solutions for automated investment accounting, performance reporting, and analytics. It serves a wide range of clients, including corporations, insurance companies, and asset managers. The company competes with other financial technology firms that offer similar services.

On January 26, 2026, Kevin McVeigh from UBS set a price target of $24.55 for CWAN. At that time, the stock was trading at $24.18, showing a slight difference of 1.53% from the target. This target aligns with the terms of a proposed sale of CWAN to Permira and Warburg Pincus, which offers shareholders $24.55 per share in cash.

Kahn Swick & Foti, LLC is investigating the fairness of this proposed sale. The investigation, led by former Louisiana Attorney General Charles C. Foti, Jr., aims to determine if the offer adequately values CWAN and if the sale process was fair. Shareholders concerned about the valuation or their legal rights are encouraged to contact the firm.

Currently, CWAN's stock price is $24.18, reflecting a slight decrease of 0.43% with a change of $0.105. The stock has traded between $24.18 and $24.33 today. Over the past year, CWAN's stock has seen a high of $32 and a low of $15.73, indicating significant volatility.

CWAN's market capitalization is approximately $6.97 billion, and the trading volume on the NYSE is 9,303,736 shares. These figures highlight the company's substantial presence in the market and the interest it generates among investors.